Search results
5 FDA decisions to watch in the third quarter
BioPharma Dive· 2 days agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...
HIV breakthrough: new pre-exposure prophylaxis called lenacapavir found 100% effective in trial
The Hindu· 13 hours agoA large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new...
Cepheid wins FDA nod for fingerstick hepatitis C test
MedTech Dive· 7 days agoCepheid’s authorization establishes special controls, clearing other companies to bring similar...